Increased mortality after coronary stenting in patients treated with clopidogrel without loading dose. Evidence from a meta-analysis

Autor: Gg, Biondi-Zoccai, Agostoni P, Testa L, Abbate A, Parisi Q, Burzotta F, Carlo Trani, Mongiardo R, Vassanelli C, Lm, Biasucci

Publikováno v: Europe PubMed Central

Clopidogrel is an established alternative to ticlopidine in addition to aspirin after coronary stenting because of its hematologic safety, but its efficacy in comparison to ticlopidine is debated. We thus systematically reviewed randomized trials com

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::cea03fd13ff63a8f2326ccc738db1b8b
https://pubmed.ncbi.nlm.nih.gov/15194981

Clinical relevance of apoptosis in early and late post-infarction left ventricular remodeling

Autor: Abbate A, Biondi-Zoccai G, Petrolini A, Lm, Biasucci, Alfonso Baldi

Publikováno v: Scopus-Elsevier
Europe PubMed Central

Apoptosis may represent an important pathophysiological mechanism causing progressive myocardiocyte loss and left ventricular dilation, even late after acute myocardial infarction (AMI). This review discusses the role of myocardial apoptosis on the b

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::9f72fef3b5e4b59a33bc783159896bc7
http://www.scopus.com/inward/record.url?eid=2-s2.0-0036954067&partnerID=MN8TOARS

Levosimendan for acute right heart failure in COVID-19: another arrow in our quiver?

Autor: Cribari F; Catholic University of the Sacred Heart, Rome, Italy. marialucia.narducci@policlinicogemelli.it., Conte C, Ruggio A, Narducci ML, D'Aiello A, Pedicino D, Biasucci LM, Liuzzo G

Publikováno v: European review for medical and pharmacological sciences [Eur Rev Med Pharmacol Sci] 2022 Aug; Vol. 26 (15), pp. 5596-5600.

Prevalence and characteristics of myocardial injury during COVID-19 pandemic: A new role for high-sensitive troponin.

Autor: Maino A; Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. Electronic address: alessandro.maino01@icatt.it., Di Stasio E; Dipartimento di Scienze biotecnologiche di base, cliniche intensivologiche e perioperatorie, Università Cattolica del Sacro Cuore, Roma, Italy; Dipartimento di scienze laboratoristiche ed infettivologiche, UOC Chimica, Biochimica e Biologia Molecolare Clinica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy., Grimaldi MC; Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Cappannoli L; Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Rocco E; Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Vergallo R; Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Biscetti F; U.O.C. Clinica Medica e Malattie Vascolari, Catholic University School of Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Laboratory of Vascular Biology and Genetics, Università Cattolica del Sacro Cuore, Rome, Italy., Baroni S; Dipartimento di Scienze biotecnologiche di base, cliniche intensivologiche e perioperatorie, Università Cattolica del Sacro Cuore, Roma, Italy; Dipartimento di scienze laboratoristiche ed infettivologiche, UOC Chimica, Biochimica e Biologia Molecolare Clinica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy., Urbani A; Dipartimento di Scienze biotecnologiche di base, cliniche intensivologiche e perioperatorie, Università Cattolica del Sacro Cuore, Roma, Italy; Dipartimento di scienze laboratoristiche ed infettivologiche, UOC Chimica, Biochimica e Biologia Molecolare Clinica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy., Landolfi R; U.O.C. Clinica Medica e Malattie Vascolari, Catholic University School of Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Division of Internal Medicine, Università Cattolica del Sacro Cuore, Rome, Italy., Biasucci LM; Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Department of Cardiovascular and Pulmonary Sciences, Università Cattolica Sacro Cuore, Rome, Italy.

Publikováno v: International journal of cardiology [Int J Cardiol] 2021 Sep 01; Vol. 338, pp. 278-285. Date of Electronic Publication: 2021 Jun 19.

Response by Russo et al Regarding Article, "Healed Plaques in Patients With Stable Angina Pectoris".

Autor: Russo M; From the Cardiology Division (M.R., F.F., O.K., H.O.K., V.T., M.A., H.S., T. Sugiyama, E.Y., I.-K.J.), Massachusetts General Hospital, Harvard Medical School, Boston., Fracassi F; From the Cardiology Division (M.R., F.F., O.K., H.O.K., V.T., M.A., H.S., T. Sugiyama, E.Y., I.-K.J.), Massachusetts General Hospital, Harvard Medical School, Boston., Kurihara O; From the Cardiology Division (M.R., F.F., O.K., H.O.K., V.T., M.A., H.S., T. Sugiyama, E.Y., I.-K.J.), Massachusetts General Hospital, Harvard Medical School, Boston., Kim HO; From the Cardiology Division (M.R., F.F., O.K., H.O.K., V.T., M.A., H.S., T. Sugiyama, E.Y., I.-K.J.), Massachusetts General Hospital, Harvard Medical School, Boston., Thondapu V; From the Cardiology Division (M.R., F.F., O.K., H.O.K., V.T., M.A., H.S., T. Sugiyama, E.Y., I.-K.J.), Massachusetts General Hospital, Harvard Medical School, Boston., Araki M; From the Cardiology Division (M.R., F.F., O.K., H.O.K., V.T., M.A., H.S., T. Sugiyama, E.Y., I.-K.J.), Massachusetts General Hospital, Harvard Medical School, Boston., Shinohara H; From the Cardiology Division (M.R., F.F., O.K., H.O.K., V.T., M.A., H.S., T. Sugiyama, E.Y., I.-K.J.), Massachusetts General Hospital, Harvard Medical School, Boston., Sugiyama T; From the Cardiology Division (M.R., F.F., O.K., H.O.K., V.T., M.A., H.S., T. Sugiyama, E.Y., I.-K.J.), Massachusetts General Hospital, Harvard Medical School, Boston., Yamamoto E; From the Cardiology Division (M.R., F.F., O.K., H.O.K., V.T., M.A., H.S., T. Sugiyama, E.Y., I.-K.J.), Massachusetts General Hospital, Harvard Medical School, Boston., Lee H; Biostatistics Center (H.L.), Massachusetts General Hospital, Harvard Medical School, Boston., Vergallo R; Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Department of Cardiovascular and Thoracic Sciences, Catholic University of the Sacred Heart, Rome, Italy (R.V., F.C., L.M.B.)., Crea F; Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Department of Cardiovascular and Thoracic Sciences, Catholic University of the Sacred Heart, Rome, Italy (R.V., F.C., L.M.B.)., Biasucci LM; Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Department of Cardiovascular and Thoracic Sciences, Catholic University of the Sacred Heart, Rome, Italy (R.V., F.C., L.M.B.)., Yonetsu T; Department of Interventional Cardiology, Tokyo Medical and Dental University, Japan (T.Y.)., Minami Y; Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Japan (Y.M.)., Soeda T; Department of Cardiovascular Medicine, Nara Medical University, Japan (T. Soeda)., Fuster V; Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York City, NY (V.F.)., Jang IK; From the Cardiology Division (M.R., F.F., O.K., H.O.K., V.T., M.A., H.S., T. Sugiyama, E.Y., I.-K.J.), Massachusetts General Hospital, Harvard Medical School, Boston.; Division of Cardiology, Kyung Hee University Hospital, Seoul, South Korea (I.-K.J.).

Publikováno v: Arteriosclerosis, thrombosis, and vascular biology [Arterioscler Thromb Vasc Biol] 2020 Sep; Vol. 40 (9), pp. e258-e259. Date of Electronic Publication: 2020 Aug 26.